vTv Therapeutics (VTVT) Tops Q1 EPS by 5c

vTv Therapeutics (NASDAQ: VTVT) reported Q1 EPS of ($0.06), $0.05 better than the analyst estimate of ($0.11).

For earnings history and earnings-related data on vTv Therapeutics (VTVT) click here.

You May Also Be Interested In

• NIO Inc. (NIO) Tops Q2 EPS by 33c; offers guidance
• Morgan Stanley Downgrades Smith & Nephew PLC. (SN:LN) (SNN) to Equalweight
• MongoDB stock tumbles despite earnings beat on profit-taking